Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3064% above fair value
$8.60+0.68 (+8.59%)
Close on Nov 18, 2026Market cap $187.29MP/E –Yield –
Alpha Cognition revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Alpha Cognition's revenue for the twelve months ending Jun 30, 2026 was $15.26M. For fiscal 2025 it was $10.22M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.22M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.09M | +267.6% |
| Q1 FY2026 | Mar 31, 2026 | $3.53M | +20.7% |
| Q4 FY2025 | Dec 31, 2025 | $2.79M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.84M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.66M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.93M | – |
See a number that looks wrong?